Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
The pheochromocytomas are an important cause of secondary hypertension. Although pheochromocytoma susceptibility may be associated with germline mutations in the tumor-suppressor genes VHL and NF1 and in the proto-oncogene RET, the genetic basis for most cases of nonsyndromic familial pheochromocytoma is unknown. Recently, pheochromocytoma susceptibility has been associated with germline SDHD mutations. Germline SDHD mutations were originally described in hereditary paraganglioma, a dominantly inherited disorder characterized by vascular tumors in the head and the neck, most frequently at the carotid bifurcation. The gene products of two components of succinate dehydrogenase, SDHC and SDHD, anchor the gene products of two other components, SDHA and SDHB, which form the catalytic core, to the inner-mitochondrial membrane. Although mutations in SDHC and in SDHD may cause hereditary paraganglioma, germline SDHA mutations are associated with juvenile encephalopathy, and the phenotypic consequences of SDHB mutations have not been defined. To investigate the genetic causes of pheochromocytoma, we analyzed SDHB and SDHC, in familial and in sporadic cases. Inactivating SDHB mutations were detected in two of the five kindreds with familial pheochromocytoma, two of the three kindreds with pheochromocytoma and paraganglioma susceptibility, and 1 of the 24 cases of sporadic pheochromocytoma. These findings extend the link between mitochondrial dysfunction and tumorigenesis and suggest that germline SDHB mutations are an important cause of pheochromocytoma susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, a biallelic loss of succinate dehydrogenase (SDH), an alteration found in familial paragangliomas and pheochromocytomas, as well as in a subset of sporadic gastrointestinal stromal tumors, creates a build-up of succinate (Astuti et al., 2001; Janeway et al., 2011).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Astuti et al., 2001
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The results of a clinical study further confirmed this observation by showing that patients with nonmetastatic lung cancer harbored loss-of-function mutations in SDH5128.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
Experimental — accuracy not yet measuredIn the citing paper
“In cancer cells, mutations in succinate dehydrogenase subunit B (SDHB) cause susceptibility to familial pheochromocytoma99 and familial paraganglioma100 as well as gastrointestinal stromal tumors101.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [99]
In the citing paper
“In addition to the tumorigenic effects of succinate accumulation, SDH5 mutation is the key driver supporting the acquisition of epithelial–mesenchymal transition (EMT) characteristics.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 3×
“…the iron-sulfur–protein subunit) and in both SDHC and SDHD (i.e., the genes for the integral membrane–protein subunits) are associated with neoplasia (Baysal et al. 2000; Niemann and Muller 2000; present study), autosomal recessive homozygous SDHA (i.e., the gene for the flavoprotein subunit)…”
BackgroundOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundCockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050 · cited 1×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 4×
“…herein: PGL1 (MIM 168000), which results from SDHD mutations at 11q23; PGL2 (MIM 601650), which maps to 11q13, although the causative gene has not been identified (Mariman et al. 1995); and PGL3 (MIM 605373), which results from SDHC mutations at 1q21 (Baysal et al. 2000; Niemann and Muller 2000).”
BackgroundInfluentialBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 2×
“SDHA mutations are associated with juvenile encephalopathy (Bourgeron et al. 1995), and the phenotypic consequences of SDHB mutations have not been defined.”
BackgroundHoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382 · cited 1×
“Interestingly, germline VHL mutations that predispose patients to pheochromocytoma do not impair HIF-1a ubiquitylation (Clifford et al. 2001; Hoffman et al. 2001).”
BackgroundClifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Gimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Self-citation
Cited by
Items 701–800 of 999
Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations
Smestad, J. A., & Maher, L. J., III (2019) · BMC Cancer · doi:10.1186/s12885-019-5813-z · Cited by 12
Gregorio, E. D., Miolo, G., Saorin, A., Steffan, A., & Corona, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115574 · Cited by 12
“The breakthrough for the Warburg revival coincided with the finding of specific mutated genes encoding for enzymes of the tricarboxylic acid (TCA) cycle as the succinate dehydrogenase (SDH) [25,26] and fumarate hydratase (FH) [27].”
BackgroundA RET Mutation with Decreased Penetrance in the Family of a Patient with a
Arum, S., Dahia, P. L. M., Schneider, K. A., & Braverman, L. E. (2005) · Endocrine · doi:10.1385/endo:28:2:193 · Cited by 12
Self-citationIntraoperative Detection of Ganglioneuromas With 123I-MIBG
van Hulsteijn, L. T., van der Hiel, B., Smit, J. W. A., Stokkel, M. P. M., & Corssmit, E. P. M. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31825add9b · Cited by 11
Saito, T., Saito, Y., Matsumura, K., Tsubota, Y., Maniwa, T., Kaneda, H., Minami, K.-I., Sakaida, N., Uemura, Y., Kawa, G., et al. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-178 · Cited by 11
Forno, B. D., Zingaro, C., Palma, E. D., Capestro, F., Rescigno, G. U., & Torracca, L. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.01.072 · Cited by 11
The malignant potential of a succinate dehydrogenase subunit B germline mutation
Gómez, C. F., Menéndez, E., Pineda, J. J., de Esteban, J. P. M., Anda, E., Goñi, M. J., Bausch, B., & Neumann, H. P. H. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344107 · Cited by 11
No fumarate hydratase (FH) mutations in hereditary prostate cancer
Lehtonen, R., Kiuru, M. H., Rökman, A., Ikonen, T., Cunningham, J. M., Schaid, D. J., Matikainen, M., Nupponen, N. N., Karhu, A., Kallioniemi, O.-P., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.3.e19 · Cited by 12
MALIGNANT PHEOCHROMOCYTOMA ASSOCIATED WITH GERMLINE MUTATION OF THE SDHB GENE
Allibhai, Z. A., Rodrigues, G., Brecevic, E., Neumann, H. P. H., & Winquist, E. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000137892.89141.6a · Cited by 11
An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years
Elston, M. S., Benn, D. E., Robinson, B. G., & Conaglen, J. V. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01023.x · Cited by 9
Stölting, G., Vo, K. N. T., Haus, J., & Scholl, U. I. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01020-6 · Cited by 17
“Mutations in the succinate dehydrogenase (SDH) subunit genes SDHA 62 , SDHB 63 , SDHC 64 and SDHD 65 , as well as in the SDH cofactor gene SDHAF2 (which encodes succinate dehydrogenase assembly factor 2, mitochondrial 66 ), cause hereditary paraganglioma– phaeochromocytoma syndrome.”
Advances in the diagnostic imaging of pheochromocytomas
Forssell-Aronsson, E. B., Shuler, E., & Ahlman, H. (2011) · Reports in Medical Imaging · doi:10.2147/rmi.s5571 · Cited by 9
“The familial PGL syndromes form a relatively new group of disorders with mutations in subunits of the mitochondrial enzyme succinate dehydrogenase (SDH): type 1 relates to benign parasympathetic PGL in the head–neck region with SDHD mutations,(18) type 2 was just recently described (SDH5 mutations),(19) type 3 also re…”
The epigenetic–metabolic interplay in gliomagenesis
Phasaludeen, B., Emerald, B. S., & Ansari, S. A. (2022) · Open Biology · doi:10.1098/rsob.210350 · Cited by 10
“For example, most mediastinal PGLs were related to SDHD gene mutations [93], whereas germline mutations of SDHB and SDHC play a minor role in sporadic head and neck PGL [94].”
BackgroundBioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly
Chu, Y., Chen, C.-W. D., Lai, M., Lim, S., & Lin, W.-R. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i29.4499 · Cited by 13
Jandová, J., Eshaghian, A., Shi, M., Li, M., King, L. E., Janda, J., & Sligh, J. E. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.320 · Cited by 11
“…M anuscript and mutations in subunits of the succinate dehydrogenase gene (SDHB, SHDC, SDHD) have been associated with paragangliomas, pheochromocytomas and renal cell carcinomas (Baysal et al., 2000; Niemann and Muller 2000; Astuti et al., 2001; Lehtonen et al., 2004; Vanharanta et al., 2004).”
BackgroundMitochondrial Disorders Due to Nuclear OXPHOS Gene Defects
Ugalde, C., Morán, M., Blázquez, A., Arenas, J., & Martín, M. A. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-2813-6_7 · Cited by 12
“SDHB Complex II deficiency Hereditary paraganglioma/pheochromocytoma (PGL4) Cowden syndrome [12]”
BackgroundShuch, B. M., Mmonu, N. A., Ricketts, C. J., Vocke, C. D., Gautam, R., Merino, M. J., Linehan, W. M., & Srinivasan, R. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.0214 · Cited by 10
Paraganglioma: The role of genetic counselling and radiological screening
Dundee, P. E., Clancy, B., Wagstaff, S. M., & Briggs, R. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.04.010 · Cited by 10
Bacca, A., Franceschini, S. S., Carrara, D., Bernini, M., Zampa, V., Taddei, S., Miccoli, P., Congregati, C., Simi, P., Ferrari, M., et al. (2012) · Head & Neck · doi:10.1002/hed.22910 · Cited by 12
“For each gene, coding regions and exon–intron boundaries were amplified by polymerase chain reaction (PCR), as previously described.(15) PCR products purified with a commercial kit (PCR purification kit; QIAGEN, Milan, Italy) were subjected to 2% agarose gel electrophoresis with ethidium bromide staining and subsequen…”
Methodp53 Alterations and Their Relationship to SDHD Mutations in Parasympathetic Paragangliomas
van Nederveen, F. H., Dannenberg, H., Sleddens, H. F. B. M., de Krijger, R. R., & Dinjens, W. N. M. (2003) · Modern Pathology · doi:10.1097/01.mp.0000084111.03922.4d · Cited by 11
“Since then, mutations in other subunits, B (SDHB) and C (SDHC) of complex II, have also been found to predispose to paraganglioma development (8, 9).”
Multiple pheochromocytomas and paragangliomas in a young patient carrying a SDHD gene mutation
Novosel, A., Heger, A., Lohse, P., & Schmidt, H. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1538-2 · Cited by 11
“In one study, mutations in RET, vHL, SDHB, and SDHD were found in 24% of patients with a non-syndromic pheochromocytoma [8].”
BackgroundInfluentialGenetics of pheochromocytoma and paraganglioma
Benn, D. E., Marsh, D. J., & Robinson, B. G. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200202000-00010 · Cited by 9
Piazza, C., Lancini, D., Tomasoni, M., Zafereo, M., Poorten, V. V., Hanna, E. Y., Mäkitie, A. A., Fernández‐Álvarez, V., Kowalski, L. P., Chiesa-Estomba, C. M., et al. (2024) · Head & Neck · doi:10.1002/hed.27624 · Cited by 9
Gabiache, G., Zadro, C., Rozenblum, L., Vezzosi, D., Mouly, C., Thoulouzan, M., Guimbaud, R., Otal, P., Dierickx, L., Rousseau, H., et al. (2023) · Cancers · doi:10.3390/cancers15184666 · Cited by 10
“Genetic testing is an essential component of not only patient management, follow-up, and prognostication, but also for election of an optimal imaging modality [20].”
Seabrook, A., Vasudevan, A., Neville, K. A., Gerstl, B., Benn, D. E., Smith, J. M., Kirk, J., Gill, A. J., Clifton-Bligh, R. J., & Tucker, K. (2023) · Archives of Disease in Childhood · doi:10.1136/archdischild-2023-325419 · Cited by 9
Phenotype of SDHB mutation carriers in the Netherlands
van Hulsteijn, L. T., Niemeijer, N. D., Hes, F. J., Bayley, J., Tops, C. M. J., Jansen, J. C., & Corssmit, E. P. M. (2014) · Familial Cancer · doi:10.1007/s10689-014-9738-z · Cited by 10
“encoding subunits A, B, C, D or assembly factor 2 of the mitochondrial complex II-succinate dehydrogenase (SDH) [3–7], TMEM127 or MAX [8, 9].”
MethodPitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas—Case Report
Canu, L., Rapizzi, E., Zampetti, B., Fucci, R., Nesi, G., Richter, S., Qin, N., Giaché, V., Bergamini, C., Parenti, G., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4453 · Cited by 11
Wang, C., Chen, T., Chang, Y., Ko, J., Yang, T., Lo, F., Hu, Y., Chen, P., Wu, C., & Lou, P. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.08.025 · Cited by 10
Carotid body tumors are not associated with an increased risk for sleep-disordered breathing
van Hulsteijn, L. T., van Duinen, N., Ninaber, M. K., Romijn, J. A., van Dijk, J. G., van Kralingen, K. W., Havekes, B., Smid, L., Lammers, G. J., Jansen, J. C., et al. (2013) · Sleep And Breathing · doi:10.1007/s11325-013-0855-y · Cited by 11
“Germline mutations in subunits A, B, C, D, or assembly factor 2 of the succinate dehydrogenase (SDH) gene cause familial PGLs [2–6].”
BackgroundA Full Phenotype of Paraganglioma Linked to a Germline SDHB Mosaic Mutation
Cardot-Bauters, C., Carnaille, B. M. L., Aubert, S., Crépin, M., Boury, S., Burnichon, N., & Pigny, P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00175 · Cited by 9
Uchenunu, O., Zhdanov, A. V., Hutton, P., Jovanović, P., Wang, Y., Andreev, D. E., Hulea, L., Papadopoli, D. J., Avizonis, D. Z., Baranov, P. V., et al. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13398 · Cited by 11
Possible autocrine enkephalin regulation of catecholamine release in human pheochromocytoma cells
Pellizzari, E. H., Barontini, M., Figuerola, M. D. L., Cigorraga, S. B., & Levin, G. M. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.07.004 · Cited by 9
Allelic loss of chromosomes 8 and 19 in MENX‐associated rat pheochromocytoma
Shyla, A., Hölzlwimmer, G., Calzada‐Wack, J., Bink, K., Tischenko, O., Guilly, M., Chevillard, S., Samson, E., Graw, J., Atkinson, M. J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24925 · Cited by 9
Oishi, Y., Nagai, S., Yoshida, M., Fujisawa, S., Sazawa, A., Shinohara, N., Nonomura, K., Matsuno, K., & Shimizu, C. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-023 · Cited by 9
Pai, R. B., Ebenazer, A., Paul, M. J., Thomas, N., Nair, A. A., Seshadri, M., Oommen, R., Shanthly, N., Devasia, A., Rebekah, G. J., et al. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1376989 · Cited by 9
GERM-LINE MUTATIONS IN NONSYNDROMIC PHEOCHROMOCYTOMA
Eumann, P. H. N., Ausch, B. I. B., Hinney, A. R. M. C. W., Imm, O. L. G., Ranke, G. E. F., Chipper, J. O. S., Lisch, J. O. K., Ltehoefer, C. A. A., Erres, K. L. Z., Anuszewicz, A. N. J., et al. (2002) · Cited by 9
Carotid Body Tumors in Humans Caused by a Mutation in the Gene for Succinate Dehydrogenase D (SDHD)
Dahan, A., Taschner, P. E. M., Jansen, J. C., van der Mey, A. G. L., Teppema, L. J., & Cornelisse, C. J. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-387-27023-x_12 · Cited by 10
Bonache, S., Martínez, J., Fernández, M., Bassas, L., & Larriba, S. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2006.00730.x · Cited by 12
Novel SDHD germ‐line mutations in pheochromocytoma patients
Neumayer, C., Moritz, A., Asari, R., Weinhäusel, A., Hölzenbein, T., Kretschmer, G., Niederle, B., & Haas, O. A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01822.x · Cited by 9
Kokko, A., Ylisaukko‐oja, S. K., Kiuru, M. H., Takatalo, M. S., Salmikangas, P., Tuimala, J., Arango, D., Karhu, A., Aaltonen, L. A., & Jäntti, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21423 · Cited by 11
Cardiometabolic disease and cardio-oncology: Insights from iPSC models and tissue engineering
Kojic, A., Moslehi, J. J., Ky, B., & Wu, J. C. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102261 · Cited by 14
Hart, M. L., Sokolov, D., Danquah, S., Zheng, E., Doan, A. D., Davidsen, K., MacPherson, D. P., & Sullivan, L. B. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01524-w · Cited by 11
Huang, B.-L., Liu, Q., Teng, Y.-Y., Peng, S., Liu, Z., Li, M., Liang, J., Zhang, Y., & Wang, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1167796 · Cited by 11
“(19) (total link strength = 11,185), Neumann HPH et al.”
BackgroundPhaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes
Maher, E. R. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-4-440 · Cited by 8
Self-citationInnate and Adaptive Immunity Linked to Recognition of Antigens Shared by Neural Crest-Derived Tumors
Donato, G., Presta, I., Arcidiacono, B., Vismara, M. F. M., Donato, A., Garo, N. C., & Malara, N. (2020) · Cancers · doi:10.3390/cancers12040840 · Cited by 8
“Germline mutations in the tumor-suppressor gene VHL, both in human cancers and in mouse models, resulting in upregulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the α-subunits of the HIF-1 and the HIF-2 transcription factors [73].”
BackgroundThe Influence of Young Age on Difficulties in the Surgical Resection of Carotid Body Tumors
Katagiri, K., Shiga, K., Ikeda, A., Saito, D., Oikawa, S., Tsuchida, K., Miyaguchi, J., Kusaka, T., Tamura, A., Nakayama, M., et al. (2021) · Cancers · doi:10.3390/cancers13184565 · Cited by 8
Kim, M. S., Muratore, C., Snelling, L. K., Mandelbaum, D. E., McEachern, R., Mangray, S., Faizan, M., & Quintos, J. B. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.6.565 · Cited by 8
Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome
Lendvai, N. K., Tóth, M., Valkusz, Z., Bekő, G., Szücs, N., Csajbók, É., Igaz, P., Kriszt, B., Kovács, B., Rácz, K., et al. (2012) · Clinics · doi:10.6061/clinics/2012(sup01)15 · Cited by 9
Molecular genetic aspects and pathophysiology of endocrine hypertension
Fountoulakis, S., & Tsatsoulis, A. A. (2006) · HORMONES · doi:10.14310/horm.2002.11173 · Cited by 10
Hoekstra, A. S., van den Ende, B., Julià, X. P., van Breemen, L., Scheurwater, K., Tops, C. M. J., Malinoc, A., Devilee, P., Neumann, H. P. H., & Bayley, J.-P. (2016) · Clinical Genetics · doi:10.1111/cge.12843 · Cited by 10
“Endocr Relat Cancer 2015: 22 (4): T91–T103.”
BackgroundPereira, M. A. A., Ferraz‐de‐Souza, B., Freire, D. S., & Lucón, A. M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500022 · Cited by 18
Liu, W., Sun, Y., Ge, W., Zhang, F., Gan, L., Zhu, Y., Guo, T., & Liu, K. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100187 · Cited by 8
“6A, B), and when mutated, is closely related 165 to pheochromocytoma [40].”
BackgroundPapilloedema secondary to a spinal paraganglioma
Bush, K. J., & Bateman, D. E. (2013) · Practical Neurology · doi:10.1136/practneurol-2013-000620 · Cited by 8
Pugh, C. W. (2003) · Annals of Medicine · doi:10.1080/07853890310017062 · Cited by 11
Unveiling the hidden role of SDHA in breast cancer proliferation: a novel therapeutic avenue
Yong, L., Fang, Y., Jin, L., Zhang, X., Luis, M. A., Lin, X., Tang, S., & Cai, F. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03746-6 · Cited by 7
The evolving roles of pathologists in paragangliomas and pheochromocytomas
Mete, Ö., & Juhlin, C. C. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04379-w · Cited by 10
“SDHx -related tumors constitute the largest hereditary subgroup and can involve mutations in SDHA , SDHB , SDHC , SDHD , or SDHAF2 , as well as SDHC promoter hypermethylation (epimutation) [9, 32–34].”
SDHA related phaeochromocytoma and paraganglioma: review and clinical management
Kaplan, A. I., Dwight, T., Luxford, C., Benn, D. E., & Clifton-Bligh, R. J. (2024) · Endocrine Related Cancer · doi:10.1530/erc-24-0111 · Cited by 20
Metastatic pheochromocytomas and paragangliomas: where are we?
Prinzi, N., Corti, F., Torchio, M., Niger, M., Antista, M., Pagani, F., Beninato, T., Pulice, I., Rossi, R. E., Coppa, J. C., et al. (2022) · Tumori Journal · doi:10.1177/03008916221078621 · Cited by 7
Garibaldi, E., Bresciani, S., Panaia, R., Delmastro, E., Malinverni, G., & Gabriele, P. (2011) · Tumori Journal · doi:10.1177/030089161109700214 · Cited by 7
Domingues, R., Montalvão, P., Magalhães, M. J., Santos, R. M., Duarte, L., & Bugalho, M. J. (2012) · PubMed · doi:10.3275/8237 · Cited by 9
A Case of Malignant Pheochromocytoma with Holt-Oram Syndrome
Yoshihara, A., Tanabe, A., Saito, H., Hizuka, N., Ishizawa, A., Horikawa, R., & Takano, K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-011 · Cited by 7
Molecular Cytogenetic Characterization in Four Pediatric Pheochromocytomas and Paragangliomas
Vícha, A., Holzerová, M., Křepelová, A., Musil, Z., Procházka, P., Sumerauer, D., Kodet, R., Eckschlager, T., & Jarošová, M. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9385-8 · Cited by 7
Milione, M., Pusceddu, S., Gasparini, P., Melotti, F., Maisonneuve, P., Mazzaferro, V., de Braud, F., & Pelosi, G. (2012) · Cancers · doi:10.3390/cancers4030808 · Cited by 7
Kopf- und Halsparagangliome: Eine interdisziplinäre Herausforderung
Künzel, J., Bahr, K., Hainz, M., Rossmann, H., & Matthias, C. (2015) · HNO · doi:10.1007/s00106-015-0085-7 · Cited by 7
Intracranial Epidural Metastases of Adrenal Pheochromocytoma: A Rare Entity
Boettcher, L. B., Abou‐Al‐Shaar, H., Ravindra, V. M., Horn, J., Palmer, C. A., & Menacho, S. T. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.03.126 · Cited by 7
Wallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 10
Rakheja, D., Khokhar, S., Mitui, M., & Cost, N. G. (2012) · Pediatric and Developmental Pathology · doi:10.2350/12-01-1151-oa.1 · Cited by 8
Anatomy, physiology, and genetics of paragangliomas
Kim, Y., & Goldenberg, D. (2015) · Operative Techniques in Otolaryngology-Head and Neck Surgery · doi:10.1016/j.otot.2015.12.003 · Cited by 7
Dekker, P. B. D., Kuipers‐Dijkshoorn, N. J., Hogendoorn, P. C. W., van der Mey, A. G. L., & Cornelisse, C. J. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00237-5 · Cited by 7
Qi, X.-P., Liu, W., Li, J., Dai, Y., Ma, J., Zhao, Y., FEI, J., Li, F., SHEN, M., Jin, H.-Y., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1578 · Cited by 7
“MAX Component of the MYC-MAX-MXD1 Autosomal dominant inheritance of bilateral PCC, confirming (21) (14q23) network and regulates cell proliferation, the association between genetic abnormalities and multiple differentiation and apoptosis. tumors.”
BackgroundInfluentialAnalysis of succinate dehydrogenase subunit B gene alterations in gastric cancers
Cao, Z., Song, J. H., Kang, Y. W., Yoon, J., Nam, S. W., Lee, J. Y., & Park, W. S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02558.x · Cited by 8
Maher, E. R. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl002 · Cited by 9
Self-citationStructure-(Dys)function Relationships in Mitochondrial Electron Transport Chain Complex II?
Kristal, B. S., & Krasnikov, B. F. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.5.pe3 · Cited by 8
Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma
Lalloo, F. I. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-29998-3_7 · Cited by 7
Sarkadi, B., Likó, I., Nyírő, G., Igaz, P., Butz, H., & Patócs, A. (2021) · Cancers · doi:10.3390/cancers13164219 · Cited by 9
Janecke, A., Willett-Brozick, J. E., Karas, C., Hasipek, M., Löffler‐Ragg, J., & Baysal, B. E. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2009.142 · Cited by 8
Hereditary urological cancer syndromes
Jefferson, K. P., & Gillatt, D. A. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0761 · Cited by 7
“1–p35, which encodes subunit B of succinate dehydrogenase”
BackgroundLaparoscopic Excision of a Familial Paraganglioma
Kelliher, K. M., Santiago, A. H., Estrada, E., & Campbell, B. T. (2009) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2008.0136.supp · Cited by 6
“It does seem, however, that head and neck paragangliomas are more often associated with SDHD , rather than SDHB , mutations, 16,17 and although this was not the case in our patient, SDHB mutations seem to be associated with an increased rate of malignancy (up to 50%).”
Histopathology of Parasellar Neoplasms
Manojlović-Gačić, E., Rostami, E., Karavitaki, N., & Casar‐Borota, O. (2020) · Neuroendocrinology · doi:10.1159/000507084 · Cited by 9
Genetic approaches to understand cellular responses to oxygen availability
Ortmann, B. M., & Nathan, J. A. (2021) · FEBS Journal · doi:10.1111/febs.16072 · Cited by 7
A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers
Hansel, D. E. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.05.016 · Cited by 7
Paragangliomas in Carney–Stratakis Syndrome
Khurana, A., Mei, L., Faber, A. C., Smith, S. C., & Boikos, S. A. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0918-8340 · Cited by 7
Familial pheochromocytomas and paragangliomas: Stories from the sign-out room
Perren, A. A., & Komminoth, P. (2006) · Endocrine Pathology · doi:10.1007/s12022-006-0005-1 · Cited by 6
Yamashita, R., Usui, T., Hashimoto, S., Suzuki, H., Takahashi, M., Honkura, K., Iwamoto, K., KODAMA, E., Tagami, T., Naruse, M., et al. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-111 · Cited by 6
Krebs cycle enzymes as tumor suppressors
Baysal, B. E. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.012 · Cited by 6
Role of SDHAF2 and SDHD in von Hippel–Lindau Associated Pheochromocytomas
Kugelberg, J., Welander, J., Schiavi, F., Fassina, A., Bäckdahl, M., Larsson, C., Opocher, G., Söderkvist, P., Dahia, P. L. M., Neumann, H. P. H., et al. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2373-2 · Cited by 7
“In contrast, mutations in SDHD [33], SDHB [34], SDHC [35], and SDHA [36] were initially found in PGLs but later also in PCCs (SDHD [37, 38], SDHB [34], SDHC [11], SDHA [39]).”
BackgroundSelf-citationAngiogenic and anti-angiogenic factors in adrenal tumours.
Jurczyńska, J., Zieleniewski, W., Stepien, H., & Komorowski, J. (2006) · PubMed · Cited by 5
Grody, W. W., Wu, J. T., Nagle, R. B., Curiel, D. T., Douglas, J. T., Nickoloff, J. A., Hoekstra, M. F., & Nickoloff, J. A. (2005) · Cited by 6
Lin, D., Lin, J., Li, X., Zhang, J., Lai, P., Mao, Z., Zhang, L., Zhu, Y., & Liu, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01181 · Cited by 7
“Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.”
BackgroundPeterson, L. A., Litzendorf, M. E., Ringel, M. D., & Vaccaro, P. S. (2014) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2013.12.012 · Cited by 7
Heritable and Syndromic Pheochromocytoma and Paraganglioma
Kopp, P. A. (2018) · Contemporary Endocrinology · doi:10.1007/978-3-319-77048-2_4 · Cited by 5
Bhagavan, N. V., & Ha, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416687-5.00030-0 · Cited by 7
Salle, S. P., Dumas, N., Bédard, K., Jolin, J., Moramarco, J., Lacroix, A., Lévesque, I., Burnichon, N., Gimenez‐Roqueplo, A., & Bourdeau, I. (2021) · Clinical Endocrinology · doi:10.1111/cen.14618 · Cited by 6
“After 2000, SDHB, SDHC and SDHD were identified as predisposing PPGLs genes.(10,11) In the following years, genes were added to the genetic testing panels as they were discovered: SDHA (2010),(12) SDHAF2 (2010),(13) TMEM127 (2010)(14) and MAX (2012).”
BackgroundAlzahrani, A. S., Alswailem, M. M., Murugan, A. K., Alghamdi, B., & Al‐Hindi, H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac076 · Cited by 6
“All exons and exon-intron boundaries of the SDHB gene were initially amplified in the peripheral DNA using primers and amplification conditions as previously described [26].”
MethodR27X nonsense mutation of the SDHB gene in a patient with sporadic malignant paraganglioma
Naito, M., Usui, T., Tamanaha, T., Kawashima, S., Iogawa, H., Hagiwara, H., Kimura, T., Tagami, T., Kurosawa, M., Shimatsu, A., et al. (2009) · Endocrine · doi:10.1007/s12020-009-9204-0 · Cited by 5
Prasad, P. K., Kant, J. A., Wills, M. L., O’Leary, M. F., Lovvorn, H. N., & Yang, E. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.04.009 · Cited by 6
“Single-nucleotide missense, nonsense, and frameshift mutations, as well as large deletions, have been identified in the SDHB gene [2,8,9].”
BackgroundFamilial Paragangliomas: Case Report and Literature Review
Vijan, S. S., Ibrahim, Z., Thompson, G. B., Schaff, H. V., & Young, W. F. (2008) · Endocrine Practice · doi:10.4158/ep.14.5.603 · Cited by 6
Molecular diagnostics and mitochondrial dysfunction: a future perspective
Siciliano, G., Pasquali, L., Mancuso, M., & Murri, L. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.4.531 · Cited by 5
Paragangliomes tympaniques et jugulaires
Huy, P. T. B., & Duet, M. (2003) · Encyclopédie médico-chirurgicale. Oto-rhino-laryngologie · doi:10.1016/s0246-0351(03)00075-8 · Cited by 5
Metabolism of Cell Growth and Proliferation
DeBerardinis, R. J., & Thompson, C. B. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10014-7 · Cited by 11
Metadata
- Authors
- Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R.
- Affiliations
- University of Birmingham (GB)
- Dana-Farber Cancer Institute (US)
- Royal Victoria Infirmary (GB)
- Queen Elizabeth Hospital (GB)
- Uppsala University (SE)
- University of Cambridge (GB)
- Corresponding author
- Maher, Eamonn R.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 69
- Issue
- 1
- Pages
- 49-54
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1226047
- OpenAlex
- W2025719835
- Cited by
- 1,087
- References
- 28
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 18 · 2023: 31 · 2022: 29 · 2021: 40 · 2020: 29 · 2019: 51 · 2018: 42 · 2017: 47 · 2016: 54 · 2015: 46 · 2014: 70 · 2013: 61 · 2012: 75
- FWCI
- 37.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4401 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation
- National Cancer Institute (P-30-CA-16058, P30CA016058)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- succinate dehydrogenase, SDHB, SDHC, pheochromocytoma, paraganglioma, germline mutations, mitochondrial dysfunction, sporadic pheochromocytoma, tumor suppressor, RET proto-oncogene, VHL, neurofibromatosis type 1
- MeSH terms
- Proto-Oncogene Mas, Amino Acid Sequence, Base Sequence, DNA Mutational Analysis, Female, Haplotypes, Humans, Male, Molecular Sequence Data, Mutation, Paraganglioma, Pedigree, Pheochromocytoma, Succinate Dehydrogenase, Sequence Alignment, Germ-Line Mutation, Loss of Heterozygosity, Genetic Predisposition to Disease, Mutation, Missense, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.